Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1991 May;87(5):1724–1731. doi: 10.1172/JCI115190

Apolipoprotein C-III(Lys58----Glu). Identification of an apolipoprotein C-III variant in a family with hyperalphalipoproteinemia.

A von Eckardstein 1, H Holz 1, M Sandkamp 1, W Weng 1, H Funke 1, G Assmann 1
PMCID: PMC295277  PMID: 2022742

Abstract

Apolipoprotein C-III is a major protein constituent of triglyceride rich lipoproteins and HDL. It occurs in plasma in three isoforms differing by their sialic acid content. Apo C-III putatively inhibits lipolysis and the apo E mediated hepatic uptake of remnants from triglyceride rich particles. We identified a heterozygous carrier of an apolipoprotein C-III variant by the presence of additional bands after isoelectric focusing (IEF) of VLDL. Structural analysis of the variant protein by HPLC, time-of-flight secondary ion mass spectrometry, and automated gas phase sequencing revealed a lysine to glutamic acid replacement in position 58. The underlying A to G exchange was verified by direct sequencing subsequent to amplification by polymerase chain reaction of exon 4 of the apo C-III gene. Family studies revealed vertical transmission of this defect. The two variant carriers exhibited plasma concentrations of HDL cholesterol and apo A-I above the 95th percentiles of sex matched controls whereas the unaffected father and sister showed normal values. The plasma concentrations of apo C-III in the two variant carriers were decreased by 30-40% compared with those of the two unaffected family members and to random controls. Using two-dimensional immunoelectrophoresis as well as IEF and subsequent scanning densitometry, we found that the low serum concentration of apo C-III was a consequence of diminished concentrations of the variant apo C-III isoproteins in both VLDL (15% of normal) and HDL (25% of normal). Apo C-III(Lys58----Glu) heterozygotes possessed unusual HDL as demonstrated by nondenaturing gradient gel electrophoresis. They consisted mainly of HDL2b and contained a proportion of atypically large particles, enriched in apo E, with a Stokes diameter of 13-18 nm and resembling HDLc. In conclusion, heterozygosity for a structural apo C-III variant--apo C-III(Lys58----Glu)--was identified in two hyperalphalipoproteinemic subjects characterized by the presence of low plasma apo C-III concentrations and atypically large HDL.

Full text

PDF
1724

Images in this article

1726Image
on p.1726
1726Image
on p.1726
1726Image
on p.1726
1727Image
on p.1727
1727Image
on p.1727
1727Image
on p.1727
1728Image
on p.1728
1728Image
on p.1728
1729Image
on p.1729
1729Image
on p.1729

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altland K., Hackler R., Knoche W. Double one-dimensional electrophoresis of human serum transferrin: a new high-resolution screening method for genetically determined variation. Hum Genet. 1980;54(2):221–231. doi: 10.1007/BF00278977. [DOI] [PubMed] [Google Scholar]
  2. Breslow J. L. Apolipoprotein genetic variation and human disease. Physiol Rev. 1988 Jan;68(1):85–132. doi: 10.1152/physrev.1988.68.1.85. [DOI] [PubMed] [Google Scholar]
  3. Brewer H. B., Jr, Shulman R., Herbert P., Ronan R., Wehrly K. The complete amino acid sequence of alanine apolipoprotein (apoC-3), and apolipoprotein from human plasma very low density lipoproteins. J Biol Chem. 1974 Aug 10;249(15):4975–4984. [PubMed] [Google Scholar]
  4. Brown M. L., Inazu A., Hesler C. B., Agellon L. B., Mann C., Whitlock M. E., Marcel Y. L., Milne R. W., Koizumi J., Mabuchi H. Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins. Nature. 1989 Nov 23;342(6248):448–451. doi: 10.1038/342448a0. [DOI] [PubMed] [Google Scholar]
  5. Brown W. V., Baginsky M. L. Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein. Biochem Biophys Res Commun. 1972 Jan 31;46(2):375–382. doi: 10.1016/s0006-291x(72)80149-9. [DOI] [PubMed] [Google Scholar]
  6. Brown W. V., Levy R. I., Fredrickson D. S. Further characterization of apolipoproteins from the human plasma very low density lipoproteins. J Biol Chem. 1970 Dec 25;245(24):6588–6594. [PubMed] [Google Scholar]
  7. Brown W. V., Levy R. I., Fredrickson D. S. Studies of the proteins in human plasma very low density lipoproteins. J Biol Chem. 1969 Oct 25;244(20):5687–5694. [PubMed] [Google Scholar]
  8. Carlson L. A., Holmquist L., Nilsson-Ehle P. Deficiency of hepatic lipase activity in post-heparin plasma in familial hyper-alpha-triglyceridemia. Acta Med Scand. 1986;219(5):435–447. doi: 10.1111/j.0954-6820.1986.tb03337.x. [DOI] [PubMed] [Google Scholar]
  9. Chou P. Y., Fasman G. D. Conformational parameters for amino acids in helical, beta-sheet, and random coil regions calculated from proteins. Biochemistry. 1974 Jan 15;13(2):211–222. doi: 10.1021/bi00699a001. [DOI] [PubMed] [Google Scholar]
  10. Chou P. Y., Fasman G. D. Prediction of protein conformation. Biochemistry. 1974 Jan 15;13(2):222–245. doi: 10.1021/bi00699a002. [DOI] [PubMed] [Google Scholar]
  11. Datta S., Li W. H., Ghosh I., Luo C. C., Chan L. Structure and expression of dog apolipoprotein C-II and C-III mRNAs. Implications for the evolution and functional constraints of apolipoprotein structure. J Biol Chem. 1987 Aug 5;262(22):10588–10593. [PubMed] [Google Scholar]
  12. Eisenberg S., Olivecrona T. Very low density lipoprotein. Fate of phospholipids, cholesterol, and apolipoprotein C during lipolysis in vitro. J Lipid Res. 1979 Jul;20(5):614–623. [PubMed] [Google Scholar]
  13. Fidge N. H., Nestel P. J. Identification of apolipoproteins involved in the interaction of human high density lipoprotein3 with receptors on cultured cells. J Biol Chem. 1985 Mar 25;260(6):3570–3575. [PubMed] [Google Scholar]
  14. Frenkel B., Mayorek N., Hertz R., Bar-Tana J. The hypochylomicronemic effect of beta,beta'-methyl-substituted hexadecanedioic acid (MEDICA 16) is mediated by a decrease in apolipoprotein C-III. J Biol Chem. 1988 Jun 15;263(17):8491–8497. [PubMed] [Google Scholar]
  15. Friedewald W. T., Levy R. I., Fredrickson D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972 Jun;18(6):499–502. [PubMed] [Google Scholar]
  16. Funke H., von Eckardstein A., Pritchard P. H., Karas M., Albers J. J., Assmann G. A frameshift mutation in the human apolipoprotein A-I gene causes high density lipoprotein deficiency, partial lecithin: cholesterol-acyltransferase deficiency, and corneal opacities. J Clin Invest. 1991 Jan;87(1):371–376. doi: 10.1172/JCI114997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ginsberg H. N., Le N. A., Goldberg I. J., Gibson J. C., Rubinstein A., Wang-Iverson P., Norum R., Brown W. V. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo. J Clin Invest. 1986 Nov;78(5):1287–1295. doi: 10.1172/JCI112713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Gordon D. J., Rifkind B. M. High-density lipoprotein--the clinical implications of recent studies. N Engl J Med. 1989 Nov 9;321(19):1311–1316. doi: 10.1056/NEJM198911093211907. [DOI] [PubMed] [Google Scholar]
  19. Gyllensten U. B., Erlich H. A. Generation of single-stranded DNA by the polymerase chain reaction and its application to direct sequencing of the HLA-DQA locus. Proc Natl Acad Sci U S A. 1988 Oct;85(20):7652–7656. doi: 10.1073/pnas.85.20.7652. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. HAVEL R. J., EDER H. A., BRAGDON J. H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955 Sep;34(9):1345–1353. doi: 10.1172/JCI103182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Havel R. J., Kane J. P., Kashyap M. L. Interchange of apolipoproteins between chylomicrons and high density lipoproteins during alimentary lipemia in man. J Clin Invest. 1973 Jan;52(1):32–38. doi: 10.1172/JCI107171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Hunt S. C., Hasstedt S. J., Kuida H., Stults B. M., Hopkins P. N., Williams R. R. Genetic heritability and common environmental components of resting and stressed blood pressures, lipids, and body mass index in Utah pedigrees and twins. Am J Epidemiol. 1989 Mar;129(3):625–638. doi: 10.1093/oxfordjournals.aje.a115175. [DOI] [PubMed] [Google Scholar]
  23. Hwang J., Menon K. M. Binding of apolipoprotein A-I and A-II after recombination with phospholipid vesicles to the high density lipoprotein receptor of luteinized rat ovary. J Biol Chem. 1985 May 10;260(9):5660–5668. [PubMed] [Google Scholar]
  24. Ito Y., Breslow J. L., Chait B. T. Apolipoprotein C-III0 lacks carbohydrate residues: use of mass spectrometry to study apolipoprotein structure. J Lipid Res. 1989 Nov;30(11):1781–1787. [PubMed] [Google Scholar]
  25. Jabs H. U., Assmann G. Characterization of an apolipoprotein C-III mutant by high-performance liquid chromatography and time-of-flight secondary ion mass spectrometry. J Chromatogr. 1987 Mar 6;414(2):323–333. doi: 10.1016/0378-4347(87)80057-9. [DOI] [PubMed] [Google Scholar]
  26. Jabs H. U., Assmann G., Greifendorf D., Benninghoven A. High performance liquid chromatography and time-of-flight secondary ion mass spectrometry: a new dimension in structural analysis of apolipoproteins. J Lipid Res. 1986 Jun;27(6):613–621. [PubMed] [Google Scholar]
  27. Karathanasis S. K., Ferris E., Haddad I. A. DNA inversion within the apolipoproteins AI/CIII/AIV-encoding gene cluster of certain patients with premature atherosclerosis. Proc Natl Acad Sci U S A. 1987 Oct;84(20):7198–7202. doi: 10.1073/pnas.84.20.7198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Karathanasis S. K., Zannis V. I., Breslow J. L. Isolation and characterization of cDNA clones corresponding to two different human apoC-III alleles. J Lipid Res. 1985 Apr;26(4):451–456. [PubMed] [Google Scholar]
  29. Kinnunen P. K., Ehnolm C. Effect of serum and C-apoproteins from very low density lipoproteins on human postheparin plasma hepatic lipase. FEBS Lett. 1976 Jun 15;65(3):354–357. doi: 10.1016/0014-5793(76)80145-7. [DOI] [PubMed] [Google Scholar]
  30. Koizumi J., Mabuchi H., Yoshimura A., Michishita I., Takeda M., Itoh H., Sakai Y., Sakai T., Ueda K., Takeda R. Deficiency of serum cholesteryl-ester transfer activity in patients with familial hyperalphalipoproteinaemia. Atherosclerosis. 1985 Dec;58(1-3):175–186. doi: 10.1016/0021-9150(85)90064-4. [DOI] [PubMed] [Google Scholar]
  31. Krauss R. M., Herbert P. N., Levy R. I., Fredrickson D. S. Further observations on the activation and inhibition of lipoprotein lipase by apolipoproteins. Circ Res. 1973 Oct;33(4):403–411. doi: 10.1161/01.res.33.4.403. [DOI] [PubMed] [Google Scholar]
  32. Kurasawa T., Yokoyama S., Miyake Y., Yamamura T., Yamamoto A. Rate of cholesteryl ester transfer between high and low density lipoproteins in human serum and a case with decreased transfer rate in association with hyperalphalipoproteinemia. J Biochem. 1985 Dec;98(6):1499–1508. doi: 10.1093/oxfordjournals.jbchem.a135418. [DOI] [PubMed] [Google Scholar]
  33. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  34. Laurell C. B. Electroimmuno assay. Scand J Clin Lab Invest Suppl. 1972;124:21–37. doi: 10.3109/00365517209102748. [DOI] [PubMed] [Google Scholar]
  35. Lohse P., Kindt M. R., Rader D. J., Brewer H. B., Jr Genetic polymorphism of human plasma apolipoprotein A-IV is due to nucleotide substitutions in the apolipoprotein A-IV gene. J Biol Chem. 1990 Jun 15;265(17):10061–10064. [PubMed] [Google Scholar]
  36. Lusis A. J. Genetic factors affecting blood lipoproteins: the candidate gene approach. J Lipid Res. 1988 Apr;29(4):397–429. [PubMed] [Google Scholar]
  37. Maeda H., Hashimoto R. K., Ogura T., Hiraga S., Uzawa H. Molecular cloning of a human apoC-III variant: Thr 74----Ala 74 mutation prevents O-glycosylation. J Lipid Res. 1987 Dec;28(12):1405–1409. [PubMed] [Google Scholar]
  38. Maeda H., Uzawa H., Kamei R. Unusual familial lipoprotein C-III associated with apolipoprotein C-III-O preponderance. Biochim Biophys Acta. 1981 Sep 24;665(3):578–585. doi: 10.1016/0005-2760(81)90273-3. [DOI] [PubMed] [Google Scholar]
  39. Menzel H. J., Boerwinkle E., Schrangl-Will S., Utermann G. Human apolipoprotein A-IV polymorphism: frequency and effect on lipid and lipoprotein levels. Hum Genet. 1988 Aug;79(4):368–372. doi: 10.1007/BF00282179. [DOI] [PubMed] [Google Scholar]
  40. Menzel H. J., Kladetzky R. G., Assmann G. One-step screening method for the polymorphism of apolipoproteins A-I, A-II, and A-IV. J Lipid Res. 1982 Aug;23(6):915–922. [PubMed] [Google Scholar]
  41. Mitchel Y. B., Rifici V. A., Eder H. A. Characterization of the specific binding of rat apolipoprotein E-deficient HDL to rat hepatic plasma membranes. Biochim Biophys Acta. 1987 Feb 14;917(2):324–332. doi: 10.1016/0005-2760(87)90137-8. [DOI] [PubMed] [Google Scholar]
  42. Neville D. M., Jr Molecular weight determination of protein-dodecyl sulfate complexes by gel electrophoresis in a discontinuous buffer system. J Biol Chem. 1971 Oct 25;246(20):6328–6334. [PubMed] [Google Scholar]
  43. Nichols A. V., Krauss R. M., Musliner T. A. Nondenaturing polyacrylamide gradient gel electrophoresis. Methods Enzymol. 1986;128:417–431. doi: 10.1016/0076-6879(86)28084-2. [DOI] [PubMed] [Google Scholar]
  44. Norum R. A., Lakier J. B., Goldstein S., Angel A., Goldberg R. B., Block W. D., Noffze D. K., Dolphin P. J., Edelglass J., Bogorad D. D. Familial deficiency of apolipoproteins A-I and C-III and precocious coronary-artery disease. N Engl J Med. 1982 Jun 24;306(25):1513–1519. doi: 10.1056/NEJM198206243062503. [DOI] [PubMed] [Google Scholar]
  45. Ordovas J. M., Cassidy D. K., Civeira F., Bisgaier C. L., Schaefer E. J. Familial apolipoprotein A-I, C-III, and A-IV deficiency and premature atherosclerosis due to deletion of a gene complex on chromosome 11. J Biol Chem. 1989 Oct 5;264(28):16339–16342. [PubMed] [Google Scholar]
  46. Protter A. A., Levy-Wilson B., Miller J., Bencen G., White T., Seilhamer J. J. Isolation and sequence analysis of the human apolipoprotein CIII gene and the intergenic region between the apo AI and apo CIII genes. DNA. 1984 Dec;3(6):449–456. doi: 10.1089/dna.1.1984.3.449. [DOI] [PubMed] [Google Scholar]
  47. Redgrave T. G., Roberts D. C., West C. E. Separation of plasma lipoproteins by density-gradient ultracentrifugation. Anal Biochem. 1975 May 12;65(1-2):42–49. doi: 10.1016/0003-2697(75)90488-1. [DOI] [PubMed] [Google Scholar]
  48. Roghani A., Zannis V. I. Mutagenesis of the glycosylation site of human ApoCIII. O-linked glycosylation is not required for ApoCIII secretion and lipid binding. J Biol Chem. 1988 Dec 5;263(34):17925–17932. [PubMed] [Google Scholar]
  49. Saiki R. K., Scharf S., Faloona F., Mullis K. B., Horn G. T., Erlich H. A., Arnheim N. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science. 1985 Dec 20;230(4732):1350–1354. doi: 10.1126/science.2999980. [DOI] [PubMed] [Google Scholar]
  50. Sandkamp M., Tambyrajah B., Schriewer H., Assmann G. Simplified turbidimetric determination of apolipoproteins A-I, A-II and B using a microtitre method. J Clin Chem Clin Biochem. 1988 Nov;26(11):685–688. doi: 10.1515/cclm.1988.26.11.685. [DOI] [PubMed] [Google Scholar]
  51. Schaefer E. J., Ordovas J. M., Law S. W., Ghiselli G., Kashyap M. L., Srivastava L. S., Heaton W. H., Albers J. J., Connor W. E., Lindgren F. T. Familial apolipoprotein A-I and C-III deficiency, variant II. J Lipid Res. 1985 Sep;26(9):1089–1101. [PubMed] [Google Scholar]
  52. Schriewer H., Jabs H. U., Assmann G. Zur enzymatischen Analytik des HDL-Sphingomyelin. J Clin Chem Clin Biochem. 1982 May;20(5):305–312. [PubMed] [Google Scholar]
  53. Schriewer H., Jung G., Emke F., Assmann G. An economical assay for HDL phosphatidyl choline. J Clin Chem Clin Biochem. 1983 Oct;21(10):611–614. doi: 10.1515/cclm.1983.21.10.611. [DOI] [PubMed] [Google Scholar]
  54. Sharpe C. R., Sidoli A., Shelley C. S., Lucero M. A., Shoulders C. C., Baralle F. E. Human apolipoproteins AI, AII, CII and CIII. cDNA sequences and mRNA abundance. Nucleic Acids Res. 1984 May 11;12(9):3917–3932. doi: 10.1093/nar/12.9.3917. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Shelburne F., Hanks J., Meyers W., Quarfordt S. Effect of apoproteins on hepatic uptake of triglyceride emulsions in the rat. J Clin Invest. 1980 Mar;65(3):652–658. doi: 10.1172/JCI109710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Sparrow J. T., Pownall H. J., Hsu F. J., Blumenthal L. D., Culwell A. R., Gotto A. M. Lipid binding by fragments of apolipoprotein C-III-1 obtained by thrombin cleavage. Biochemistry. 1977 Dec 13;16(25):5427–5431. doi: 10.1021/bi00644a004. [DOI] [PubMed] [Google Scholar]
  57. Terpstra A. H., Woodward C. J., Sanchez-Muniz F. J. Improved techniques for the separation of serum lipoproteins by density gradient ultracentrifugation: visualization by prestaining and rapid separation of serum lipoproteins from small volumes of serum. Anal Biochem. 1981 Feb;111(1):149–157. doi: 10.1016/0003-2697(81)90243-8. [DOI] [PubMed] [Google Scholar]
  58. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Vaith P., Assmann G., Uhlenbruck G. Characterization of the oligosaccharide side chain of apolipoprotein C-III from human plasma very low density lipoproteins. Biochim Biophys Acta. 1978 Jun 15;541(2):234–240. doi: 10.1016/0304-4165(78)90396-3. [DOI] [PubMed] [Google Scholar]
  60. Windler E., Chao Y., Havel R. J. Regulation of the hepatic uptake of triglyceride-rich lipoproteins in the rat. Opposing effects of homologous apolipoprotein E and individual C apoproteins. J Biol Chem. 1980 Sep 10;255(17):8303–8307. [PubMed] [Google Scholar]
  61. Windler E., Havel R. J. Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver. J Lipid Res. 1985 May;26(5):556–565. [PubMed] [Google Scholar]
  62. von Eckardstein A., Funke H., Henke A., Altland K., Benninghoven A., Assmann G. Apolipoprotein A-I variants. Naturally occurring substitutions of proline residues affect plasma concentration of apolipoprotein A-I. J Clin Invest. 1989 Dec;84(6):1722–1730. doi: 10.1172/JCI114355. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES